GAO reports. CMS spins. Patients suffer.
Medicare beneficiaries paid four times more for prescription drugs than their plan sponsors did in 2021, according to a Government Accountability Office (GAO) report on Medicare Part D drugs. According to the report, beneficiaries paid $21 billion for prescription drugs in 2021, while plan sponsors only paid about $5.3 billion, according to the study of 79 of the 100 Part D drugs with the most rebates. (Source: drugwonks.com Blog)
Source: drugwonks.com Blog - September 11, 2023 Category: Pharmaceuticals Source Type: blogs
An MBA in Regulatory Confusion
Welcome to the world of therapeutic use of tissues – an exciting and evolving arena of 21st century medicine and one of the many areas of medical products regulated by the FDA. And, as with many other areas of the agency’s jurisdiction, peculiar bureaucratic intervention and lack of clarity are causing harm to patients and costing American jobs. (Source: drugwonks.com Blog)
Source: drugwonks.com Blog - July 31, 2023 Category: Pharmaceuticals Source Type: blogs
Science: Sanity's Home Field Advantage
(Source: drugwonks.com Blog)
Source: drugwonks.com Blog - July 21, 2023 Category: Pharmaceuticals Source Type: blogs
Owning PBMs
(Source: drugwonks.com Blog)
Source: drugwonks.com Blog - July 21, 2023 Category: Pharmaceuticals Source Type: blogs
Attention Chairman Sanders, Nulla mensa sine impensa
(Source: drugwonks.com Blog)
Source: drugwonks.com Blog - July 20, 2023 Category: Pharmaceuticals Source Type: blogs
Misguided Bayou
(Source: drugwonks.com Blog)
Source: drugwonks.com Blog - June 6, 2023 Category: Pharmaceuticals Source Type: blogs
340B (Smart)
We must have an evidence-based dialogue on the 340B program to ensure all stakeholder relationships within the program are evaluated as part of ongoing policy discussions. (Source: drugwonks.com Blog)
Source: drugwonks.com Blog - January 14, 2023 Category: Pharmaceuticals Source Type: blogs
When it comes to Remdesivir, WHO Knows
(Source: drugwonks.com Blog)
Source: drugwonks.com Blog - January 21, 2022 Category: Pharmaceuticals Source Type: blogs
In Consideration of Janet Woodcock
(Source: drugwonks.com Blog)
Source: drugwonks.com Blog - October 27, 2021 Category: Pharmaceuticals Source Type: blogs
Are COVID-19 Clinical Trials Conflicted?
Assuming the FDA follows the adcomm's recommendations (and I predict they will), this is science at work. It's why the clinical trial process works. What doesn't work is when our political leadership gets out ahead of science-based regulatory decision making. A few weeks BEFORE the adcomm, President Biden announced that booster shots would be available to all Americans ages 12+. That was a mistake. It reeks of the White House trying to put it's thumb on the regulatory scale. (Source: drugwonks.com Blog)
Source: drugwonks.com Blog - September 20, 2021 Category: Pharmaceuticals Source Type: blogs
D Flat: The Sweetest Note in Healthcare
Last week 132 organizations representing older Americans, patients, family caregivers, people with disabilities, diverse communities, and healthcare providers sent a letter to our Congressional healthcare leadership urging them to address the unaffordable and out of control out-of-pocket (OOP) costs facing America ’s seniors. The timing is urgent. (Source: drugwonks.com Blog)
Source: drugwonks.com Blog - September 13, 2021 Category: Pharmaceuticals Source Type: blogs
